Theolytics has named Matilde Saggese as its new Chief Medical Officer, as the Oxford-based biotech company accelerates ...

Symeres has appointed Gabriella Gentile as Chief Operating Officer, strengthening its executive team as the company pursues ...

Santhera Pharmaceuticals has announced positive topline results from a long-term analysis of AGAMREE (vamorolone) in patients ...

The Cell and Gene Therapy Catapult (CGT Catapult) has highlighted the vital role of advanced therapies in supporting the UK Government’s goal of becoming a top three global life sciences economy by ...

Alys Pharmaceuticals has announced the dosing of the first subject in its phase 1/1b trial of ALY-301, a first-in-class mast ...

Three-year trial results reveal long-term improvements in pain and lesion resolution UCB has announced new three-year data from its BE HEARD trials for BIMZELX (bimekizumab-bkzx), showing sustained ...

ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science ...

In this edition we dare to dream – fever dream, no less – about the future of the NHS. We go beyond the current chaos and speculate about the possibilities built on the founding principles, but ...